![]() |
市場調査レポート
商品コード
1576630
コンピュータ支援検出(CAD)市場:用途別(腫瘍、心臓病)、モダリティ別(マンモグラフィ、MRI、CT、超音波)、エンドユーザー別(病院・クリニック、画像診断センター、外来診療センター) - 2031年までの世界予測Computer-aided Detection (CAD) Market by Application (Oncology, Cardiology), Modality (Mammography, MRI, CT, Ultrasound), End User (Hospitals & Clinics, Imaging Centers, Ambulatory Care Centers) - Global Forecast to 2031 |
||||||
カスタマイズ可能
|
コンピュータ支援検出(CAD)市場:用途別(腫瘍、心臓病)、モダリティ別(マンモグラフィ、MRI、CT、超音波)、エンドユーザー別(病院・クリニック、画像診断センター、外来診療センター) - 2031年までの世界予測 |
出版日: 2024年08月01日
発行: Meticulous Research
ページ情報: 英文 260 Pages
納期: 5~7営業日
|
コンピュータ支援検出(CAD)市場は、2024年から2031年までのCAGR7.4%で、2031年までに15億6,000万米ドルに達すると予測されます。
広範な2次調査と1次調査、市場シナリオの詳細な分析を経て、当レポートは主要な市場促進要因、抑制要因、課題、機会の分析から構成されています。このような成長は、慢性疾患の有病率の上昇、早期がん診断の重要性に関する意識の高まり、がん研究への投資と資金提供の増加、医療費の増加によるものです。しかし、CADソリューションのコストの高さがこの市場の成長を抑制しています。
さらに、放射線科医の間でCADが受け入れられつつあること、がん検診プログラムの増加、人工知能(AI)や機械学習(ML)の統合などCADソリューションの進歩は、この市場で事業を展開する企業に成長機会をもたらすと期待されています。しかし、CADシステムの使用に必要な技術的専門知識の不足は、市場成長に影響を与える大きな課題です。
(注:上位5社のSWOT分析を掲載)
Computer-aided Detection (CAD) Market by Application (Oncology [Breast, Lung, Colorectal, Liver], Cardiology), Modality (Mammography, MRI, CT, Ultrasound), End User (Hospitals & Clinics, Imaging Centers, Ambulatory Care Centers) - Global Forecast to 2031
The Computer-aided Detection (CAD) market is projected to reach $1.56 billion by 2031 at a CAGR of 7.4% from 2024 to 2031.
Succeeding extensive secondary and primary research and in-depth analysis of the market scenario, the report comprises the analysis of key industry drivers, restraints, challenges, and opportunities. This growth is due to the rising prevalence of chronic diseases, increasing awareness regarding the importance of early cancer diagnosis, increasing investments and funding for cancer research, and rising healthcare expenditure. However, the high costs of CAD solutions restrain the growth of this market.
Furthermore, the growing acceptance of CAD among radiologists, the increase in cancer screening programs, and advancements in CAD solutions, such as the integration of Artificial Intelligence (AI) and Machine Learning (ML), are expected to generate growth opportunities for the players operating in this market. However, the lack of technical expertise required to use CAD systems is a major challenge impacting market growth.
The report offers a competitive landscape based on an extensive assessment of the product portfolio offerings, geographic presences, and key strategic developments adopted by leading market players in the industry over four years (2021-2024). The key players operating in the global Computer-aided Detection (CAD) market are Siemens Healthineers AG (Germany), Koninklijke Philips N.V. (Netherlands), GE HealthCare Technologies Inc. (U.S.), Hologic, Inc. (U.S.), FUJIFILM Holdings Corporation (Japan), EDDA Technology, Inc. (U.S.), Canon Medical Systems Corporation (Japan), Riverain Technologies (U.S.), Median Technologies (France), Agfa-Gevaert NV (Belgium), iCAD Inc. (U.S.), CureMetrix, Inc. (U.S.), and THERAPIXEL (France).
Among all the applications studied in this report, in 2024, the oncology segment is expected to account for the largest share of the Computer-aided Detection (CAD) market. The segment's large share is attributed to the increasing prevalence of breast cancer and the increase in breast cancer detection and awareness campaigns. Breast cancer ranks among the most prevalent cancers affecting women globally. According to the World Health Organization (WHO), 2.3 million breast cancer cases were recorded globally in 2020, and this number is expected to reach 3 million by 2040. The rising incidence of breast cancer has led to a rapid increase in the adoption of innovative technologies, such as CAD, aimed at enhancing breast cancer detection through a combination of various modalities.
Among all the imaging modalities studied in this report, in 2024, the mammography segment is expected to account for the larger share of the Computer-aided Detection (CAD) market. Computer-aided mammograms offer improved accuracy in diagnosis as the images can be zoomed in on, upgraded, or adjusted for more in-depth evaluation. Also, computer-aided mammography enables early identification of breast cancer in patients with no symptoms. These factors contribute to the segment's large share.
Among all the end users studied in this report, in 2024, the hospitals & clinics segment is expected to account for the largest share of the Computer-aided Detection (CAD) market. The segment's large share is attributed to the rising prevalence of cancer, the growing number of hospitals and clinics, the availability of highly skilled professionals in hospitals and clinics, the high purchasing power of hospitals, and the increasing patient population seeking comprehensive healthcare services, including diagnosis, treatment, and surgical procedures.
An in-depth analysis of the geographical scenario of the global Computer-aided Detection (CAD) market provides detailed qualitative and quantitative insights into the five major geographies (North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa) along with the coverage of major countries in each region. In 2024, North America is expected to account for the largest share of the Computer-aided Detection (CAD) market. In the region in 2024, the U.S. is expected to account for the largest share of the Computer-aided Detection (CAD) market in North America. The large share of this regional market is attributed to the presence of major Computer-aided Detection (CAD) companies such as GE HealthCare Technologies Inc. (U.S.), and Hologic, Inc. (U.S.), increasing cancer cases, and technological advancements in cancer detection and diagnosis.
Computer-aided Detection (CAD) Market Assessment-by Application
Note: Other applications include neurology, diabetic retinopathy, and tuberculosis.
Computer-aided Detection (CAD) Market Assessment-by Imaging Modality
Note: Other imaging modalities include X-ray imaging and endoscopy.
Computer-aided Detection (CAD) Market Assessment-by End User
Computer-aided Detection (CAD) Market Assessment-by Geography
(Note: SWOT analyses of the top 5 companies will be provided.)